Haleon plc has a 52 week low of $7.89 and a 52 week high of $10.80. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44. About Haleon ...

Haleon, a global consumer health company, is investing $54.2 million to upgrade its research & development (R&D) facility in Richmond, Virginia. The modernization will enable the company to expand ...

Haleon Trading Down 2.5 % Shares of Haleon stock opened at $9.71 on Tuesday. Haleon plc has a fifty-two week low of $7.89 and a fifty-two week high of $10.80. The firm has a market cap of $43.94 ...

RICHMOND, Va. — Haleon, a global company behind home healthcare products like Advil, Tums and Aquafresh, announced Monday its plan to upgrade its Richmond research and development facility.

Haleon, an international manufacturer of medicine, vitamins and toothpaste, will upgrade its lab in Richmond’s North Side at a cost of $54 million, the company announced Monday. Based in England ...

The UK-based pharmaceutical company Haleon will invest $54.2 million to upgrade its R&D facility in Richmond, which has helped birth or grow products such as Advil, Emergen-C and Robitussin.

Haleon plc (LSE/NYSE:HLN), a global consumer health leader with a market capitalization of $44 billion, disclosed today that two of its executives have acquired shares as part of the company's ...

Drop Duchy has just revealed its release date, but while you wait, you can try it right now thanks to its newly expanded Steam demo. As well as being different shapes, each block consists of ...

The projected fair value for Haleon is UK£5.19 based on 2 Stage Free Cash Flow to Equity Current share price of UK£3.91 suggests Haleon is potentially 25% undervalued Analyst price target for ...

In a recent regulatory filing, Haleon plc (LSE/NYSE: HLN), a prominent player in the consumer health sector with a market capitalization of $41.7 billion, disclosed its updated total number of ...

(Reuters) - Consumer healthcare company Haleon said on Wednesday it will invest $54 million in its global research and development centre in Richmond, U.S., aiming to boost its pipeline for new ...

The expansion was announced in a press conference held on Monday, Jan. 27, detailing how Haleon, a global health company, plans to invest $54.2 million for upgrades to the Richmond facility.